GoodRx logo

GoodRx(GDRX)

Emerging#14 in Healthcare

NASDAQ-listed (GDRX) prescription savings platform comparing prices across 70K+ pharmacies; $750M revenue with stock under pressure from Amazon Pharmacy and Cost Plus Drugs competition.

Best for: Prescription SavingsEmerging, rapid growth
40
AI Score
Grade C
AI Visibility Score (Beta)
HealthcarePrescription SavingsGDRXWebsiteUpdated October 2026

Brand Intelligence Graphcompany

Capabilities
Prescription Savings

Company Overview

About GoodRx

GoodRx is a Santa Monica-based prescription savings and healthcare price comparison platform that enables consumers to compare prices, access discount coupons, and find the lowest-cost pharmacy for their prescriptions — providing free price comparison tools across 70,000+ US pharmacies and a GoodRx Gold subscription ($9.99/month) with even lower prices on 1,000+ common medications. Listed on NASDAQ (NASDAQ: GDRX), GoodRx went public in September 2020 and generates approximately $750 million in annual revenue primarily from pharmaceutical industry fees and consumer subscription revenue.

Business Model & Competitive Advantage

GoodRx's business model is a three-sided marketplace: consumers use GoodRx to find the lowest price pharmacy and receive a GoodRx coupon (presented at the pharmacy counter or via app at the pharmacy register); the pharmacy bills GoodRx's pharmacy benefit manager (PBM) partner rather than the consumer's insurance; the PBM processes the claim at the negotiated GoodRx contract price and pays GoodRx a fee per transaction. GoodRx's value is the price aggregation across PBM contracts — the same drug can have dramatically different prices across different PBMs and pharmacies, and GoodRx always shows the lowest available.

Competitive Landscape 2025–2026

In 2025, GoodRx (NASDAQ: GDRX) competes in the prescription savings and pharmaceutical price transparency market with RxSaver, Blink Health, Mark Cuban's Cost Plus Drugs (a direct pharmaceutical purchasing model at cost + 15% markup), and Amazon Pharmacy for prescription cost reduction. GoodRx stock declined significantly from its $46 IPO price — trading around $4-7 in 2024-2025 — reflecting revenue headwinds from PBM renegotiations and competition from Amazon Pharmacy and Cost Plus Drugs. Amazon Pharmacy has been particularly disruptive as it offers comparable pricing with the convenience of Amazon delivery. The 2025 strategy focuses on the GoodRx Gold subscriber base, telehealth services that extend beyond prescription savings, and the pharmaceutical manufacturer savings program business (patient assistance programs) as revenue diversification beyond the PBM coupon model.

Revenue
$750M
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

GoodRx is an emerging player bringing innovative solutions to the Healthcare market.

Growth Stage

GoodRx has achieved $750M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

40
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Zocdoc logo

Zocdoc

HealthTech
AnalyticsB2bB2cHealthtechMarketplaceMobile FirstPlatformSaas

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati

Noom logo

Noom

Healthcare
StartupB2cHealthtechMobile FirstPlatform

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Compare GoodRx with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For GoodRx

Claim This Profile

Are you from GoodRx? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim GoodRx Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention GoodRx vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →